GlaxoSmithKline ( (GB:GSK) ) has issued an update.
GSK has announced the purchase of 835,000 of its own ordinary shares as part of its ongoing buyback program, executed through Citigroup Global Markets Limited. This move, which involves holding the shares in treasury, is part of a non-discretionary agreement initiated in February 2025, and it reflects GSK’s strategy to manage its capital structure and enhance shareholder value.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company operating in the pharmaceutical industry, focusing on the development and manufacturing of medicines, vaccines, and consumer healthcare products.
YTD Price Performance: 11.60%
Average Trading Volume: 8,798,990
Technical Sentiment Signal: Strong Sell
Current Market Cap: £60.45B
See more data about GSK stock on TipRanks’ Stock Analysis page.